Involving Young People in research investigating comorbidity associated with childhood-onset rheumatic disease: Perspectives of a series of focus groups

doi:10.21203/rs.3.rs-4804291/v1

Download PDF

Research Article

Involving Young People in research investigating comorbidity associated with childhood-onset rheumatic disease: Perspectives of a series of focus groups

https://doi.org/10.21203/rs.3.rs-4804291/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Background

Childhood-onset rheumatic diseases, such as juvenile idiopathic arthritis, juvenile-onset lupus and juvenile dermatomyositis, appear to be associated with an increased risk of comorbidities in adulthood compared to the general population. For the first stage of a research project evaluating this topic, we wanted to capture views from young people with juvenile-onset rheumatic disease to ensure that further work was relevant to their lived experience and priorities. This study aimed to determine (i) which comorbidities young people identify as important, (ii) how they access information about their disease, including comorbidity risk, whether (iii) they would like to hear about the risk of comorbidities whilst they are under paediatric care and (iv) would be motivated to make lifestyle choices to decrease the risk of potential comorbidities.

Methods

A topic guide based on the proposed study aims was developed, and PowerPoint slides were prepared to facilitate three focus group discussions to gain insights from young people. Focus groups were conducted via video platform, and the views of young people were assimilated using notetaking and an online interactive polling tool.

Results

A total of 18 young people between 10 and 27 years of age participated in the focus groups. Mental health (including depression and anxiety) was described as important comorbidity by 17/18 (94%), followed by obesity or being overweight by 9/18 (50%), heart disease by 7/18 (39%) and stroke by 5/18 (28%) of participants. Young people reported searching UK National Health Service websites, charity resources, and Google for information on their disease and associated comorbidities. They stated that they would be willing to change their lifestyle to reduce the risk of comorbidities if information were given to them sensitively with clear practical steps for reducing risk.

Conclusion

Three groups of young people identified risk of mental health issues, obesity, and cardiovascular morbidities as particularly important to them. They reported searching online platforms related to their disease and increasingly accessed online resources as they transitioned from paediatric to adult care. Participants thought it would be helpful to provide information on young people’s disease and associated comorbidity in a motivational and sensitive way.

Patient and public involvement

Focus groups

Juvenile Idiopathic Arthritis

Juvenile-onset Lupus

Juvenile Dermatomyositis

Comorbidity

Childhood-onset

Patient and public involvement (PPI) is an essential part of the research process and needs to be carefully and strategically planned with the assistance of a PPI specialist. It can help to improve research outcomes, contribute to carers’, clinicians’, and policymakers’ decision-making, and facilitate the allocation of provisions to meet patient priorities[1, 2]. UK health research funders have recognised the value of patient involvement in research through initiatives such as the National Institute for Health Research PPI strategic plan[3].

Patients with childhood onset rheumatic disease, such as Juvenile Idiopathic Arthritis (JIA), Juvenile-onset Systemic Lupus Erythematosus (jSLE, also known as Childhood-onset SLE), and Juvenile Dermatomyositis (JDM), may be at risk of comorbidities and adverse long-term outcomes later in life[4–6]. This may increase the risk of death or disability and has implications on their quality of life and healthcare utilisation[5, 7]. Studies reporting health outcomes and treatment priorities from the perspective of clinicians or adult patients with multimorbidity demonstrate that the priorities of patients and healthcare professionals do not always align, as patient priorities are primarily based on illness experiences and those of professionals on managing long-term risks of conditions[8]. A study on patient engagement in healthcare research has highlighted that understanding the lived experience of patients receiving medical care may be valuable in framing organisational policy and system interventions[9]. Furthermore, a study to improve comorbidity management in young patients with jSLE highlighted that young people should be involved and their voices be heard to align patient and healthcare professional expectations, promoting better healthcare outcomes[10].

This study aims to determine i) which comorbidities young people think are important, ii) how they access information about their disease, including long-term outcomes and risk of comorbidities, whether iii) young people would like to hear more about the risk of comorbidities whilst they are under paediatric care, and iv) would be motivated to make lifestyle choices to decrease the risk of potential comorbidities.

Participants

Following ethics approval, young people were invited to three focus groups, coordinated with the help of established PPI organisations that were experienced in research involving young people and relevant to the diseases evaluated. Authors (SS and LJM) co-facilitated focus groups with PPI Leads of each group. The groups participating in focus group discussions were i) Generation R Liverpool, a network alliance of young people advisory groups based around the UK that aims to support the design and delivery of paediatric health research (lived experience of healthcare but not specifically of rheumatic diseases) [11], ii) Your Rheum, a group of 11–24 years old with childhood onset rheumatic disease that offers advice to researchers[12, 13]; and iii) Lupus UK, a young people group with Lupus[14].

Preparation for focus group discussions

The authors formulated a topic guide, including questions to be asked within focus groups (shown in supplementary material) that covered the study aims. A set of PowerPoint slides was prepared based on questions and reviewed by the PPI specialist to ensure that they were age appropriate. The language was adjusted to ensure the presentation was as simple and engaging as possible. Before each meeting, slides were reviewed by the PPI leads of the respective groups. Based on their feedback on content and language, further adaptations were made. An online polling tool, Poll Everywhere, was embedded within the PowerPoint presentation to allow participants to interactively engage in discussion and elicit real-time opinions during the presentation[15]. Prior to conducting the focus groups, the presentation was piloted among clinical members of our research team to ensure that the voting system worked well and that the content and language were appropriate for patient groups.

Focus groups

Focus groups were conducted via video platform. Each session started with a welcome and introductions followed by ice-breaker questions. After an overview of the project aims, we described the three diseases (JIA, jSLE, and JDM) we plan to evaluate in future work on comorbidities. To achieve aim 1 of the study (to assess which comorbidities were important to participants), examples of comorbidities found in adult-onset disease in published literature were presented to the groups[16–21]. Young people were asked to consider these comorbidities and based on their experience with their condition, reflect on which comorbidities were important to them. To achieve aim 2 (understanding how young people access information relevant to their conditions), the groups were shown the results of ‘Answer The Public’, a Google search query, as an example of a way that the public may access information online relating to the diseases being studied[22]. This was used as an introduction to promote discussion on how young people may access information about their condition. To achieve aim 3 and 4 (whether young people would like to hear more about the risk of comorbidities whilst they are under paediatric care and if they would be motivated to make lifestyle choices to decrease the risk of potential comorbidities), they were asked open-ended questions to elicit opinions.

Eighteen young people, 11 females and four males, participated in focus groups. They were between 10 to 27 years old and attended events from 12 regions/cities across the UK. The demographic details of participants are shown in Table 1.

Table 1

Basic demographics of focus group participants.
Group Name (meeting date)	Number of participants	Mean age in years (range)	Proportion of females
Generation R (22/01/2022)	9	Mean 15.5 (10–21)	44%
Your Rheum (27/01/2022)	7	Mean 17.5 (11–24)	71%
Lupus UK (12/05/2022)	2	Mean 24.5 (22–27)	100%

Aim 1: Determining which comorbidities are important to young people.

Young people were asked to reflect on the listed comorbidities taken from published literature, including heart disease, high blood pressure, obesity or being overweight, bone disease (osteoporosis or osteopenia), stroke, diabetes, mental health disorders, and liver disease, and asked to state what they thought was important to them. Young people were also able to include other comorbidities which may be important to them. Most participants (17/18; 94%) consistently highlighted mental health as important (Table 2). Other comorbidities rated highly were obesity or overweight (9/18; 50%), heart disease (7/18; 39%), and stroke (5/18; 28%). In addition, participants mentioned liver disease (2/18, 11%), diabetes (2/18, 11%), and infertility (2/18, 11%). Some participants opted for ‘other’ and indicated that uveitis and lung disease were important.

Table 2

Results of focus group discussion identifying which comorbidities are important to Young People.
Comorbidity	Number of participants identifying each comorbidity as important to them in focus groups (total participants)			Total number of Young People (%) choosing each comorbidity as important across the groups
	Generation R (9)	Your Rheum (7)	Lupus UK (2)
Mental health/Depression/ Anxiety	9	7	1	17 (94)
Overweight/Obesity	6	3	0	9 (50)
Heart disease/Cardiovascular risk	0	7	0	7 (39)
Stroke	0	5	0	5 (28)
Diabetes	2	0	0	2 (11)
Liver disease	0	1	1	2 (11)
Infertility	0	1	1	2 (11)
Infection/Covid	1	0	0	1 (6)
Hypertension	0	0	1	1 (6)
Uveitis	0	1	0	1 (6)
Lung involvement	0	1	0	1 (6)

Aim 2: Determining how young people access information about their disease.

Young people in these groups gathered information regarding their health and illness in various ways. Eight out of nine (89%) participants from the Generation R group said they used Google to search online for information. Other sources of information included the use of UK National Health Service (NHS) websites (3/9; 33%), National Institute for Clinical Excellence, NICE (1/9; 11%), Internet Explorer (1/9; 11%), YouTube (1/9; 11%) and by asking their parents (2/9; 22%). One out of nine (11%) participants chose “videos from people with the condition” but did not specify a specific source or social media platform for videos. They expressed concern about the reliability of sources of online information and the need to be aware of misinformation. Participants stated that the source of information they used depended on the questions they were asking. When searching for information about health and disease, they ensured that the source of information was reliable by cross-checking with official NHS websites. However, they were happy to use Google if they were looking for information related to school and homework.

Similarly, the Your Rheum group (n = 7) described using a mixture of sources of information. They relied on rheumatologists or other healthcare professionals for more serious matters. Two out of seven (29%) participants looked at NHS websites and mentioned that their preferred sources of information had changed over the years. When under paediatric care, they relied on (and trusted) information from their rheumatologist or parents. Participants expressed that under paediatric care, they felt more supported, but as they transitioned to adult services, they felt that things appeared more rushed, and they were expected to do more themselves. At this stage, they were more inclined to access information from social media or Arthur's Place, an online magazine that provides resources for young people with arthritis[23]. One out of seven (14%) participants mentioned using Arthur's Place for emotional issues. They also used the Versus Arthritis website (2/7; 29%), the National Rheumatoid Arthritis Society, NRAS (2/7; 29%), Health Unlocked (a social networking service for health), Instagram, online support groups and other online forums.

Participants of the Lupus UK group (n = 2) described searching for disease-related information on Google but validating this information with other relevant websites, such as NHS resources. The Lupus UK website and its associated online platforms were considered a reliable source of information and support. The Health Unlocked platform moderated by Lupus UK and a WhatsApp group facilitated by Lupus UK were highlighted as helpful. Speaking to medical professionals was always preferable to online sources and significant to young people.

Aim 3: Determining whether young people would like to hear more about the risk of comorbidities while under paediatric care.

This section focused on how much young people would like to know about their disease and the potential associated risk of comorbidities. Young people shared that their opinions changed over time. At an earlier stage of their condition or when they were adolescents, they did not want to know details. However, they expressed that they would like to learn more about their illness as they progressed through adolescence and into adulthood. A key point from participants was that information should be given sensitively and at the right time. They also thought that young people needed to be given practical support to know how to deal with it.

When participants reflected on the long-term impact of living with these diseases, they had some concerns about the impact of disease, e.g. “struggling at school” and “limited access to sports” in the short term; “pregnancy outcomes”, “affecting future”, “affecting work-life”, “impact on quality of life” in medium-term; and “earlier death due to complications” in long-term (detailed in supplementary material). They also raised concerns about the emotional impact of disease, describing feelings such as “loneliness”, “isolation”, “sad” and “overwhelming”. However, reflecting on the long-term effects of the disease led to considering positive life changes, including opting to “manage lifestyle, diet, exercise” and “live life as normally as possible.”

Specific themes emerged based on participant responses on whether knowing more about long-term outcomes would be helpful or anxiety-inducing. Many participants thought that more information from professional sources would help them. One participant mentioned, “Yes, because I could prepare myself for the potential long-term outcomes, so it is less of a shock if it does happen.” Similarly, another related ‘’I would want to know ways to help it and ways that will make it worse for me, and it is important to know that you can still lead a normal life.’’ Also, a respondent emphasised that the availability of information could motivate them to make life changes. Others agreed that it could be useful as it could help prepare for the future, but recognised the uncertainty of whether they would be affected by a comorbidity. One young person stated, “It would help me to know and be prepared. It may cause more anxiety, but I would want to know for similar reasons.”

Some participants expressed that more information about long-term outcomes related to their disease could be scary. One respondent suggested it may be “more of a burden.” Another insightfully raised the possibility that “stress may make young people more likely to smoke or promote risk-taking behaviour/anxiety.’’ A participant expressed that ‘’more information about outlook or comorbidity may be confusing for young people, increasing anxiety, and anxiety may affect education and cause difficulty concentrating.” Similarly, another participant mentioned that ‘’because my disease is a new diagnosis, I overthink information, and particularly long-term effects would be too much and cause anxiety.’’ A participant resonated that it would be ‘’helpful but also scary and could cause people to obsess about serious conditions.’’ Furthermore, they emphasised that information on the long-term outcome or comorbidities should not be given at a younger age, or first diagnosed.

Participants highlighted that the benefit of the availability of information “depends on the person, age and the disease.” One participant described that “it depends on the treatment of the disease and how people around you deal with it; if a person accepts that this is how it is, knowing about long-term outcomes probably would not change anything. However, if it makes you more aware, you may be able to implement steps to help.’’ Some respondents suggested that healthcare professionals need to weigh up benefits and risks. They thought that if there was a high probability of getting a disease or comorbidity, it may be important to tell a young person. They also stated that knowledge of risk may impact mental health. They thought it was important to be positive where possible, e.g. ‘’low chance of cancer, but if this happens, we have treatment’’. They thought positivity was reassuring. Other participants suggested that it was important for healthcare professionals to ‘’read the signs of how much information young people want.’’

Aim 4: Determining if young people would be motivated to make lifestyle choices to decrease the risk of potential comorbidities.

Considering if knowing about the risk of comorbidities would help to manage lifestyle choices in different ways and decrease these risks, participants were optimistic in their response. They thought more information would enable them to manage their disease, lifestyles, and choices productively. One emphasised that ‘’if I knew the outcomes, I would try to change my lifestyle to try and limit the effects as much as possible.’’ Similarly, another saw this opportunity as having ‘’a significant impact on life as your doctors and care team are so knowledgeable that if they give you advice, you will want to follow it for the good of your health.’’ ‘’It is an opportunity to be more cautious.’’ Another participant responded, "Yes, I want to help it improve, not make it worse, and it would reduce risk factors.” Others suggested that they would exercise more, follow doctors’ advice, want to live as normally as possible for young people, and manage lifestyle, diet, exercise and pacing. Some participants used weight as an example. They described this as difficult to control but were ready to accept and change lifestyles. One participant commented that they now (as a young adult) understand that weight can impact joints. However, they suggested not putting too much pressure on young people but giving balanced information and being sensitive. One participant stated it “depends - you would be aware, but then you have to think about implementation, ensuring it's practical, local and realistic”, emphasising the need to practically support young people to make the necessary changes through integrated, personalised interventions to reduce the risks of comorbidities. They articulated that it can be challenging for young people when they do not have complete control of their disease, but if a professional says this will help, young people will follow it. A theme of empowerment emerged as young people saw the importance of letting a person know how to make changes (such as losing weight) in a way that was practical or in a stepwise fashion. Health Coaching was mentioned - used by GP practices, where health coaches work with people to give them small steps to change, e.g. jumping a few times whilst waiting for the kettle to boil if making a cup of tea. Other participants thought that using tools like Health Coaching could help but would be age dependent.

To the best of our knowledge, no previous studies have asked young people with juvenile onset rheumatic disease what comorbidities are important to them. In this study, young people with juvenile-onset rheumatic disease identified mental health, being obese or overweight, heart disease and stroke as important comorbidities, followed by liver disease, diabetes, and fertility-related complications of their disease. They also emphasised how chronic diseases and medications used in treatment regimens may exacerbate the risk of obesity, mental illness, infections, and infertility, among other comorbidities. The insights gained from young people during these PPI groups will be instrumental in informing further research evaluating comorbidities relating to JIA, jSLE and JDM.

The impact on mental health was a key concern for young people in this study, which aligns with previous literature. A North American study has identified that clinician-diagnosed or self-diagnosed mental health disorders were prevalent in young people with JIA, jSLE and JDM, with the most commonly reported problems being anxiety (81/123, 66%), depression (65/123, 53%) or adjustment disorder (45/123, 37%)[24]. Barriers to accessing mental health services included concerns that mental health professionals would not understand the rheumatological disease. A high proportion of patients in this study (50/85, 60%) reported using online mental health resources. There is evidence to suggest that the risk of mental health disorders is higher in childhood onset rheumatic disease than in those with adult-onset disease, raising the importance of identification, education and early intervention[25].

The participants of this study sought information on their condition, treatment and management using different sources, including NHS websites and resources from charities related to their disease. They suggested that when they searched for information using search engines, such as Google, they cross-checked the accuracy of information with other service provider information, such as NHS websites or charitable organisations. This highlighted the importance of considering a variety of online platforms to disseminate disease related information and provide educational material for patient groups. An Australian study investigated how young adults (n = 165, aged 18–24 years) interact with different social media platforms for health and health information using a web-based conversation methodology. They found that 112/165 (67.8%) of participants used social media to talk or learn about health. In particular, Facebook newsfeeds often resulted in seeing health-related content. YouTube was considered helpful, with the video format easy to learn from and credibility judged instinctively or by cross-checking multiple videos. Instagram was a source of inspiration for wellness, healthy lifestyle and fitness. A smaller group used Pinterest for health reasons, especially for recipes or workouts. Twitter, Tumblr and Snapchat were rarely used for health information[26].

A study on whether social media, along with web-based education, led to improved medication adherence among adolescents and young adults with SLE showed that an online educational intervention led to an improvement in medication adherence for all participants, but adherence was further enhanced for participants engaging in disease-centred social media forums with SLE peers compared to those without social media access[27]. A review evaluating the effects of social media on paediatric rheumatic disease suggested that social media facilitated access to online communities for patients and their families[28]. Adolescents and young adults with rare rheumatic disease have the potential to benefit significantly from online interactions with peers who share common experiences. Social media may also allow family communities to collaborate regardless of geographic distance, support each other, and advocate for their children to improve the care and awareness of the disease[28]. A study on a self-management smartphone app system for young people with JIA demonstrated that using the app provided them with opportunities and motivation for better self-management via medication reminders, easy access to information, advice, support, understanding of their behaviours, and control of their disease activity. Reading other patients' success stories and reflecting on their own disease management increased their confidence to cope with future challenges[29].

A study on podcasting as an innovative tool to enhance osteoarthritis research dissemination and education suggested that podcasting as a source of educational content may also be applicable to paediatric services[30]. Podcasts could allow young people to learn more about their disease and enable discussions. A wide range of patients may be reached by linking research outcomes to various social media platforms, enhancing knowledge of their medical condition. Social media may facilitate a platform for continued discussion among all stakeholders involved, including healthcare experts, patients, their carers and families[31].

Responses to would knowing more about long-term outcomes or co-morbidities hinders or helps to manage lifestyle, suggested that the young people included in this study would be willing to change their lifestyle to decrease the risk of comorbidities provided that information was given to them later in the course of their illness, when they were at an older age, and presented sensitively, including simple steps for how they can practically work on decreasing their risk. It is important to note that young people who choose to participate in focus groups may be particularly motivated, and this may not reflect the thoughts and feelings of all young people with childhood onset rheumatic disease. If questions are directed towards young people without any health issues or involvement in any health or research related groups, different results may be demonstrated. Additionally, more work is needed to determine if lifestyle changes will reduce long-term risk of comorbidity. Accepting these limitations, it may be appropriate to educate about the risks of comorbidities whilst preparing young people to transition to adult services. The European Alliance of Associations for Rheumatology standards and recommendations for transitional care of young people with rheumatic disease advised that holistic care includes the need to be future focused and not limited to young adulthood to ensure optimal well-being[32]. Young people may be receptive at this time to a multi-disciplinary approach that includes recommended lifestyle changes (where appropriate) and health choices that minimise the risk of comorbidities later in life.

A qualitative study involving children and young people with JDM with a range of disease duration, severity and experiences highlighted themes of “feeling different”, “sick”, “steroidal and scared”, and feeling “uncertainty” depending on what else was happening due to JDM itself or changing personal and social circumstances[33]. However, as far as we are aware, previous studies have not specifically evaluated the perceptions of young people with juvenile-onset rheumatic disease about comorbidities and counselling of risk factors. This study brings together some important points for clinicians to consider whilst supporting young people's journey to adulthood. By aligning the clinician perspective with patient priorities, better patient outcomes could be ensured.

The limitations of this study include that each group, particularly the Lupus UK group, had small numbers of participants, and the total number of participants (n = 18) in this study was modest. However, being in small groups, participants were able to engage in detailed discussions and made equal contributions to generate effective ideas. Due to social or language restrictions, patients who choose to join PPI groups might not represent the whole disease population, and tend to be more motivated patients who are actively involved in their care and receptive to health promotion activities. We did not evaluate ethnicity, sexual orientation, or social factors within this study. Because we used Poll Everywhere as a tool to gather responses, we were unable to determine the age of participants responding in any particular way. It would have been interesting to know if age or developmental stage influenced the responses given. Future research involving PPI of young people with juvenile rheumatic disease is recommended to identify specific challenges and opportunities related to the disease and associated comorbidities, including minority groups. It would also be interesting to evaluate what role social media and forums such as TikTok have in young peoples’ decision making process.

This study showed that mental health, obesity, and cardiovascular risk were key comorbidities for young people who participated in these focus groups. This study demonstrated that young people would be receptive to education about the risk of comorbidities and would be willing to make lifestyle choices to minimise risks if the information was given to them at the right stage in their illness and in a sensitive, practical way. An opportunistic time may be when young people are being prepared to transition to adult services, supported by multidisciplinary teams and disease-specific online resources. Young people's opinions elicited in this work will be used to inform further research evaluating comorbidities relating to JIA, jSLE and JDM.

JDM

Juvenile Dermatomyositis

JIA

Juvenile Idiopathic Arthritis

jSLE

Juvenile-onset systemic Lupus erythematosus

NHS

National Health Service

NICE

National Institute for Clinical Excellence

NRAS

National Rheumatoid Arthritis Society

PPI

Patient and Public Involvement and Engagement

SLE

Systemic Lupus Erythematosus

United Kingdom

United States

Ethics approval and consent to participate

The Institute of Life Course and Medical Sciences Research Ethics Committee, University of Liverpool, granted human participants access and ethical approval (ILCAMS-REC reference 10556) for this study. Written informed consent for participants was not deemed necessary and waived by the IRB Board (ILCAMS-REC reference 10556) since the work did not involve any individual patient recruitment or patient identifiable data. Participants were already part of established PPI research groups (Your Rheum, Generation R and Lupus UK) and actively chose to participate in these focus groups. Information about the study was given to participants via PPI Leads of these organisations prior to focus groups, allowing participants to decide if they wanted to take part. No patient identifiable information was kept as part of this study. Meeting notes simply included the number of young people involved in discussion and an anonymised documentation of discussion.

Consent for publication

Not applicable.

Availability of data and materials

All data generated or analysed during this study are included in this published article [and its supplementary information files].

Competing interests

The authors declare that they have no competing interests.

Funding

This work was done as part of a PhD supervision made possible with support from the Hugh Greenwood Legacy Fund. It matched funding from the Faculty of Health and Life Sciences, University of Liverpool. SSZ is supported by a National Institute for Health and Care Research (NIHR) Academic Clinical Lectureship and works in centred supported by Versus Arthritis (grant number 21173, 21754, 21755).

Author’s contributions

SS, JSA, EMDS, CEP, SSZ, DMH, and LJM were involved in the concept and design of the study. SS, JSA and LJM were involved in data acquisition. SS, DMH, and LJM analysed and interpreted the data. SS, DMH and LJM drafted the manuscript. All authors have critically reviewed the manuscript for important intellectual content and read and approved the final manuscript.

Acknowledgements

The authors wish to acknowledge PPI leads /facilitators and participants of Generation R, Your Rheum and Lupus UK including Laura Lunt, Adolescent and Young Adult Rheumatology Research Assistant.

Goel N. Enhancing patient research partner engagement: Research in psoriatic arthritis. Best Pract Res Clin Rheumatol. 2021;35(2):101685. doi: 10.1016/j.berh.2021.101685.
Kirwan JR, de Wit M, Frank L, Haywood KL, Salek S, Brace-McDonnell S, et al. Emerging Guidelines for Patient Engagement in Research. Value Health. 2017;20(3):481-6. doi: 10.1016/j.jval.2016.10.003.
National Institute for Health and Care Research. https://www.nihr.ac.uk/. Accessed 23 January 2023.
Glerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, et al. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort. Arthritis Care Res (Hoboken). 2020;72(4):507-16. doi: 10.1002/acr.23853.
Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain R, et al. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(2):290-301. doi: 10.1002/art.40697.
Tsaltskan V, Aldous A, Serafi S, Yakovleva A, Sami H, Mamyrova G, et al. Long-term outcomes in Juvenile Myositis patients. Semin Arthritis Rheum. 2020;50(1):149-55. doi: 10.1016/j.semarthrit.2019.06.014.
Moorthy LN, Peterson MGE, Hassett AL, Lehman TJA. Burden of childhood-onset arthritis. 2010;8:20.
Sathanapally H, Sidhu M, Fahami R, Gillies C, Kadam U, Davies MJ, et al. Priorities of patients with multimorbidity and of clinicians regarding treatment and health outcomes: a systematic mixed studies review. BMJ Open. 2020;10(2):e033445. doi: 10.1136/bmjopen-2019-033445.
Brys N KJ, Knobloch MJ, et al. Engaging patients in health care epidemiology research: A case example. American Journal of Infection Control. 2019;47:139−43. doi: 10.1016/j.ajic.2018.08.013.
Ciurtin C, Robinson GA, Pineda-Torra I, Jury EC. Comorbidity in young patients with juvenile systemic lupus erythematosus: how can we improve management? Clin Rheumatol. 2022;41(4):961-4. doi: 10.1007/s10067-022-06093-3.
Generation R. https://generationr.org.uk. Accessed 22 January 2022.
Your Rheum. https://yourrheum.org. Accessed 27 January 2022.
Esen E, Gnanenthiran S, Lunt L, McDonagh JE, Your R. The Your Rheum story: involvement of young people in rheumatology research. BMC Rheumatol. 2022;6(1):43. doi: 10.1186/s41927-022-00273-z.
LUPUS UK. https://lupusuk.org.uk/. Accessed 12 May 2022.
Poll Everywhere. https://www.polleverywhere.com/. Accessed 02 January 2022.
Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2019;33(3):101423. doi: 10.1016/j.berh.2019.06.005.
Zhao SS, Radner H, Siebert S, Duffield SJ, Thong D, Hughes DM, et al. Comorbidity burden in axial spondyloarthritis: a cluster analysis. Rheumatology (Oxford). 2019;58(10):1746-54. doi: 10.1093/rheumatology/kez119.
Gupta S, Syrimi Z, Hughes DM, Zhao SS. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int. 2021;41(2):275-84. doi: 10.1007/s00296-020-04775-2.
Chang-Fu Kuo I-JC, Frances Rees, Matthew J Grainge, Peter Lanyon, Graham Davenport, Christian Mallen, Ting-Ting Chung, Jung-Sheng Chen, Weiya Zhang, Michael Doherty. Temporal relationships between systemic lupus erythematosus and comorbidities. 2019.
Syue SH, Chang YH, Shih PJ, Lin CL, Yeh JJ, Kao CH. Polymyositis/dermatomyositis is a potential risk factor for acute respiratory failure: a pulmonary heart disease. Ann Transl Med. 2020;8(5):202. doi: 10.21037/atm.2020.01.56.
Keyes E, Grinnell M, Jacoby D, Vazquez T, Diaz D, Werth VP, et al. Assessment and management of the heightened risk for atherosclerotic cardiovascular events in patients with lupus erythematosus or dermatomyositis. Int J Womens Dermatol. 2021;7(5Part A):560-75. doi: 10.1016/j.ijwd.2021.08.015.
Answer The Public. https://answerthepublic.com/. Accessed 12 December 2021.
Arthur's Place: A magazine and social network for young adults with arthritis. https://arthursplace.co.uk/. Accessed 25 January 2022.
Fawole OA, Reed MV, Harris JG, Hersh A, Rodriguez M, Onel K, et al. Engaging patients and parents to improve mental health intervention for youth with rheumatological disease. Pediatr Rheumatol Online J. 2021;19(1):19. doi: 10.1186/s12969-021-00503-7.
Davis AM, Rubinstein TB, Rodriguez M, Knight AM. Mental health care for youth with rheumatologic diseases - bridging the gap. Pediatr Rheumatol Online J. 2017;15(1):85. doi: 10.1186/s12969-017-0214-9.
Lim MSC, Molenaar A, Brennan L, Reid M, McCaffrey T. Young Adults' Use of Different Social Media Platforms for Health Information: Insights From Web-Based Conversations. J Med Internet Res. 2022;24(1):e23656. doi: 10.2196/23656.
Scalzi LV, Hollenbeak CS, Mascuilli E, Olsen N. Improvement of medication adherence in adolescents and young adults with SLE using web-based education with and without a social media intervention, a pilot study. Pediatr Rheumatol Online J. 2018;16(1):18. doi: 10.1186/s12969-018-0232-2.
Hausmann JS, Weitzman ER. The Promises and Perils of Social Media for Pediatric Rheumatology. Rheum Dis Clin North Am. 2022;48(1):233-43. doi: 10.1016/j.rdc.2021.09.005.
Cai RA, Beste D, Chaplin H, Varakliotis S, Suffield L, Josephs F, et al. Developing and Evaluating JIApp: Acceptability and Usability of a Smartphone App System to Improve Self-Management in Young People With Juvenile Idiopathic Arthritis. JMIR Mhealth Uhealth. 2017;5(8):e121. doi: 10.2196/mhealth.7229.
Mobasheri A, Costello KE. Podcasting: An innovative tool for enhanced osteoarthritis education and research dissemination. Osteoarthr Cartil Open. 2021;3(1):100130. doi: 10.1016/j.ocarto.2020.100130.
Sandalova E, Ledford JG, Baskaran M, Dijkstra S. Translational Medicine in the Era of Social Media: A Survey of Scientific and Clinical Communities. Front Med (Lausanne). 2019;6:152. doi: 10.3389/fmed.2019.00152.
Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, et al. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017;76(4):639-46. doi: 10.1136/annrheumdis-2016-210112.
Livermore P, Gray S, Mulligan K, Stinson JN, Wedderburn LR, Gibson F. Being on the juvenile dermatomyositis rollercoaster: a qualitative study. Pediatr Rheumatol Online J. 2019;17(1):30. doi: 10.1186/s12969-019-0332-7.

No competing interests reported.

Supplementarymaterial.doc

Download PDF

Reviews received at journal
15 Sep, 2024
Reviewers agreed at journal
06 Sep, 2024
Reviews received at journal
02 Sep, 2024
Reviewers agreed at journal
29 Aug, 2024
Reviewers invited by journal
25 Aug, 2024
Editor invited by journal
16 Aug, 2024
Editor assigned by journal
16 Aug, 2024
Submission checks completed at journal
16 Aug, 2024
First submitted to journal
25 Jul, 2024

You are reading this latest preprint version

Involving Young People in research investigating comorbidity associated with childhood-onset rheumatic disease: Perspectives of a series of focus groups

Status:

Version 1

Abstract

Background

Methods

Participants

Preparation for focus group discussions

Focus groups

Results

Discussion

Conclusions

Abbreviations

Declarations

References

Additional Declarations

Supplementary Files

Status:

Version 1